Atrium Health Mercy (biopsy only) — Charlotte, North Carolina

Atrium Health Mercy (biopsy only) is a clinical research site located in Charlotte, North Carolina, United States 28207.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Atrium Health Mercy (biopsy only) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Urothelial Carcinoma.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Atrium Health Mercy (biopsy only)?

Atrium Health Mercy (biopsy only) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Atrium Health Mercy (biopsy only) conducted?

Atrium Health Mercy (biopsy only) has 1 clinical trials on record, with 1 currently active. Their work covers Urothelial Carcinoma.

Is Atrium Health Mercy (biopsy only) accredited by Crixeo Health?

Atrium Health Mercy (biopsy only) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Atrium Health Mercy (biopsy only)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.